Status:
COMPLETED
Using Differences in Peripheral Blood Leukocyte Gene Expression to Determine Cardiovascular Disease Risk
Lead Sponsor:
National Heart, Lung, and Blood Institute (NHLBI)
Conditions:
Atherosclerosis
Cardiovascular Diseases
Eligibility:
FEMALE
20-85 years
Brief Summary
Cardiovascular disease (CVD), including heart disease, heart attack, high blood pressure, and stroke, is most commonly caused by atherosclerosis, or a hardening of the arteries. Traditional risk facto...
Detailed Description
CVD is the leading cause of death worldwide and accounts for almost 40% of deaths each year in the United States. In a person with CVD, oxygenated blood is not adequately distributed throughout the bo...
Eligibility Criteria
Inclusion
- Female participant from the MESA study who has a low Framingham risk score and has either SA or no evidence of SA
- Healthy female below the age of 40 from Northwestern University.
Exclusion
- \- Diabetes
Key Trial Info
Start Date :
March 1 2007
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
February 1 2010
Estimated Enrollment :
120 Patients enrolled
Trial Details
Trial ID
NCT00613158
Start Date
March 1 2007
End Date
February 1 2010
Last Update
July 29 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Northwestern University
Chicago, Illinois, United States, 60611